【摘要】：連鎖藥店是中國(guó)藥品零售行業(yè)一個(gè)重要的組成形式。隨著經(jīng)濟(jì)的發(fā)展，人民對(duì)健康需求的增強(qiáng)，藥店經(jīng)營(yíng)能力不斷增強(qiáng)，隨著醫(yī)保新政策的推行，國(guó)家對(duì)醫(yī)療健康行業(yè)投入的加大，藥品連鎖行業(yè)的發(fā)展出現(xiàn)了一個(gè)轉(zhuǎn)型期。單體藥店將慢慢減少，連鎖藥店的規(guī)模將會(huì)越來(lái)越大，藥店只有在連鎖下才能有競(jìng)爭(zhēng)優(yōu)勢(shì)，開(kāi)展連鎖經(jīng)營(yíng)是必然的趨勢(shì)。衡陽(yáng)藥品零售市場(chǎng)放開(kāi)以后，衡陽(yáng)連鎖藥店發(fā)展迅速，各種模式連鎖藥店都出現(xiàn)在衡陽(yáng)藥品零售市場(chǎng)，初步滿足顧客的需求。衡陽(yáng)的連鎖藥店還存在門(mén)店多，規(guī)模小，忽視農(nóng)村的發(fā)展，人力資源管理低下和物流配送系統(tǒng)不到位，經(jīng)營(yíng)門(mén)店還存在攔截銷(xiāo)售和商品漏洞，多元化發(fā)展不足特許加盟店與公司合作困難等問(wèn)題。 本文采用文獻(xiàn)分析法，比較分析法，實(shí)證分析法為研究的方法，來(lái)研究中國(guó)醫(yī)藥流通體制改革、以藥品零售市場(chǎng)放開(kāi)為起點(diǎn)到2012年這段時(shí)期為研究重點(diǎn)，并在前人研究的基礎(chǔ)上，介紹了國(guó)內(nèi)藥品連鎖行業(yè)的發(fā)展過(guò)程，介紹海王星辰連鎖藥店成功的經(jīng)驗(yàn)及未來(lái)的發(fā)展趨勢(shì)，指出國(guó)內(nèi)連鎖藥店存在的問(wèn)題及三九連鎖藥店失敗的原因。研究了國(guó)外美國(guó)和日本連鎖藥店發(fā)展的歷程，其醫(yī)藥分家的體制，多元化的發(fā)展經(jīng)營(yíng)模式，以顧客為中心的服務(wù)理念，先進(jìn)的信息化管理系統(tǒng)。對(duì)衡陽(yáng)連鎖藥店的經(jīng)營(yíng)管理現(xiàn)狀及不足之處進(jìn)行了分析和研究，重點(diǎn)分析了衡陽(yáng)民生堂連鎖藥店和千禧連鎖藥店經(jīng)營(yíng)管理情況，通過(guò)對(duì)各種連鎖方式進(jìn)行研究探討，得出自建直營(yíng)店是適合衡陽(yáng)市場(chǎng)發(fā)展的模式的結(jié)論，對(duì)衡陽(yáng)藥店存在的問(wèn)題提出了相應(yīng)的對(duì)策和解決方案。期望衡陽(yáng)連鎖藥店能扭轉(zhuǎn)現(xiàn)在經(jīng)營(yíng)困難的局面，抓住新的發(fā)展機(jī)遇，走上持續(xù)健康的發(fā)展道路。
[Abstract]:Chain drugstore is an important form of Chinese drug retail industry. With the development of economy, the enhancement of people's demand for health, the ability of pharmacy to operate, along with the implementation of the new medical insurance policy and the increase of the national investment in the medical and health industry, the development of the pharmaceutical chain industry has appeared a transitional period. The size of the chain drugstore will be bigger and bigger. Only under the chain can the drugstore have the competitive advantage. It is an inevitable trend to carry out the chain operation. After the opening of Hengyang pharmaceutical retail market, Hengyang chain drugstore developed rapidly, and all kinds of model chain drugstores appeared in Hengyang drug retail market to meet the needs of customers. Hengyang's chain drugstores still have many stores, small scale, ignoring the development of rural areas, low human resources management and inadequate logistics and distribution systems, and there are also loopholes in intercepting sales and commodities in operating stores. Diversification under-developed franchised stores and company cooperation difficulties and other issues. This paper adopts literature analysis, comparative analysis and empirical analysis to study the reform of pharmaceutical circulation system in China, taking the opening of drug retail market as the starting point and the period from 2012 to 2012 as the research focus. On the basis of previous research, this paper introduces the development process of domestic drug chain industry, introduces the successful experience and future development trend of Haiwangxingchen chain drugstore. This paper points out the problems existing in the domestic chain drugstores and the reasons for the failure of the Sanjiu chain drugstores. This paper studies the development process of American and Japanese chain drugstores in foreign countries, its medical separation system, diversified development and management mode, customer-centered service concept, and advanced information management system. This paper analyzes and studies the current situation and deficiency of Hengyang chain drugstore, emphatically analyzes the management of Hengyang Minshengtang chain drugstore and Millennium chain drugstore, and probes into all kinds of chain ways. It is concluded that the self-built direct store is suitable for Hengyang market development mode, and the corresponding countermeasures and solutions are put forward to the problems existing in Hengyang drugstore. I hope Hengyang chain drugstore can reverse the current difficult situation, seize the new development opportunities, and embark on a sustainable and healthy development path.
【學(xué)位授予單位】：南華大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2013
【分類(lèi)號(hào)】：F272;F426.72

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 葉堂林;陳偉國(guó);劉煜;;經(jīng)濟(jì)全球化背景下我國(guó)醫(yī)藥連鎖經(jīng)營(yíng)的SWOT分析及戰(zhàn)略[J];商業(yè)研究;2006年07期

2 范平;邵崇鈺;;淺談零售藥店品類(lèi)管理之困境[J];當(dāng)代經(jīng)濟(jì);2011年16期

3 林瑾文;;我國(guó)醫(yī)藥零售企業(yè)的發(fā)展思路[J];海峽藥學(xué);2006年03期

4 浦昭騫;景浩;;我國(guó)連鎖藥店管理現(xiàn)狀分析與對(duì)策研究綜述[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2011年02期

5 羅容;;對(duì)連鎖藥店多元化經(jīng)營(yíng)的思考[J];商場(chǎng)現(xiàn)代化;2011年05期

6 李一平;中小型連鎖藥店采購(gòu)聯(lián)盟催發(fā)醫(yī)藥商業(yè)零售變革[J];中國(guó)衛(wèi)生產(chǎn)業(yè);2005年09期

7 陳芳;李卉;黃泰康;;新醫(yī)改背景下藥品零售企業(yè)的發(fā)展策略[J];中國(guó)藥業(yè);2009年24期

8 陳玉文;李維涅;;淺談我國(guó)藥店的會(huì)員制[J];中國(guó)藥房;2005年21期

9 梁小麗;;我國(guó)零售連鎖藥店發(fā)展現(xiàn)狀分析[J];中國(guó)實(shí)用醫(yī)藥;2010年18期

10 趙向陽(yáng);;連鎖藥店轉(zhuǎn)攻“非藥品”經(jīng)營(yíng)[J];中國(guó)商貿(mào);2010年21期

，

本文編號(hào)：2432311